Yahoo May Look to A...
Health Care: Drugs
Pharmacyclics Incorporated (PCYC: NASDAQ)
$84.89 0.97 | 1.16%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 11.99M | -35.20M | -15.02M | -23.45M |
| Operating Gains/Losses | 25.00K | -2.00K | 0.00 | -1.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -5.96M | 140.00K | 438.00K | -632.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 3.92M | 2.27M | 1.69M | 112.00K |
| (Decrease) Increase In Other Current Liabilities | 163.00K | 530.00K | -5.28M | 11.63M |
| (Increase) Decrease In Other Working Capital | 68.66M | 1.26M | -17.00K | -4.00K |
| Other Non-Cash Items | 9.87M | 7.82M | 3.19M | 3.30M |
| Net Cash From Continuing Operations | 86.09M | -22.27M | -15.47M | -8.18M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 86.09M | -22.27M | -15.47M | -8.18M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 11.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 24.50M | 75.46M | 15.01M | 7.70M |
| Purchases of Property, Plant & Equipment | -2.98M | -1.15M | -224.00K | -81.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -5.72M | -77.96M | -36.60M | -4.97M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 15.81M | -3.65M | -21.81M | 2.66M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 6.40M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 8.24M | 56.60M | 74.26M | 1.39M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | -314.00K | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 5.88M | 0.00 | 0.00 |
| Net Cash From Financing Activities | 8.24M | 62.48M | 73.94M | 7.79M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 110.14M | 36.56M | 36.66M | 2.27M |
Portfolios with PCYC
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 28
- UserGFNN Stockdiagnostics 20
- ContributorStocks Rising On Unusual Vo...
- ContributorHot Biotech Stocks Traded b...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Best-Performing Stocks i...
- ContributorStocks At New 52-Week Highs...
Latest PCYC Headlines from TheStreet
- ASCO '13 Preview: Roche's Next-Gen Rituxan Steps Up 05.15.13 | 06:05 pm
- ASCO '13 Preview: Gilead's Big Cancer Debut 05.15.13 | 06:05 pm
- 10 ASCO '13 Abstracts You Can Read Right Now 05.15.13 | 06:05 pm
- Pharmacyclics Rises On Unusually High Volume (PCYC) 05.13.13 | 03:05 pm
- 3 Biotech Stocks Spiking With Big Volume 05.13.13 | 02:05 pm
- Pharmacyclics Incorporated (PCYC): Today's Featured Drugs Winner 04.22.13 | 05:04 pm
- Pharmacyclics Incorporated (PCYC): Drugs' Featured Daily Laggard 04.09.13 | 05:04 pm
- TheStreet Ratings Top 10 Rating Changes 04.08.13 | 09:04 am
- Pharmacyclics Incorporated Stock Downgraded (PCYC) 04.05.13 | 05:04 am
- Pharmacyclics Incorporated (PCYC): Today's Featured Drugs Laggard 03.19.13 | 05:03 pm
Press Releases for PCYC
- Pharmacyclics Announces Date Of Financial Results For Three Months Ended March 31, 2013 And Conference Call - PR Newswire 04.24.13 | 04:04 pm
- Pharmacyclics Completes Enrollment Of First Phase III Ibrutinib CLL Study - RESONATEâ¿¢ And Announces Completion Of Enrollment Of Phase II Ibrutinib MCL Study - SPARK - PR Newswire 04.18.13 | 04:04 pm
- Pharmacyclics Triggers Fourth Milestone Payment For Enrollment Of 5th Patient In Frontline Phase III CLL Study - PR Newswire 04.11.13 | 06:04 am
- Phase II Ibrutinib Monotherapy Study Shows CLL Patients Achieved Rapid And Sustainable Disease Control Irrespective Of Age Or High Risk Prognostic Factor - PR Newswire 04.08.13 | 01:04 pm
- Pharmacyclics Announces Third Breakthrough Therapy Designation For Ibrutinib From The U.S. Food And Drug Administration - PR Newswire 04.08.13 | 06:04 am
- Pharmacyclics, Inc. Prices Public Offering Of Common Stock - PR Newswire 03.08.13 | 08:03 am
- Pharmacyclics, Inc. Announces Proposed Public Offering Of Common Stock - PR Newswire 03.07.13 | 04:03 pm
- Pharmacyclics First To Announce Breakthrough Therapy Designation In Oncology From The U.S. Food And Drug Administration - PR Newswire 02.12.13 | 07:02 pm
- Pharmacyclics Announces Date Of Financial Results For Three And Six Months Ended December 31, 2012 And Conference Call - PR Newswire 02.07.13 | 04:02 pm
- Pharmacyclics® Announces Updated Results For BTK Inhibitor Ibrutinib (PCI-32765) At American Society Of Hematology (ASH) Annual Meeting - PR Newswire 12.11.12 | 04:12 pm
Partner Headlines for PCYC
- Short Interest in Vertex Rises, in Celgene Falls - Benzinga 05.11.13 | 10:05 am
- Amgen, Inc. (AMGN): Today's Most Compelling Stock Buy - NASDAQ 05.09.13 | 04:05 pm
- Pharmacyclics Inc. (PCYC): Today's Most Compelling Stock Buy - NASDAQ 05.07.13 | 05:05 pm
- Polycyclics Inc. (PCYC): Today's Most Compelling Stock Pick - NASDAQ 04.26.13 | 07:04 pm
- Biotech Stocks Get A Turbo Boost From Vertex - Seeking Alpha 04.20.13 | 09:04 am
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Regeneron Pharmaceuticals Inc (REGN): Today's Most Compelling Buy - NASDAQ 03.14.13 | 04:03 pm
- Pharmacyclics Is Ripe For A Major Correction - Seeking Alpha 02.16.13 | 06:02 am
- UPDATE: Dawson James Initiates Pharmacyclics at Market Outperform on Ibrutinib Confidence - Benzinga 12.07.12 | 09:12 am
- Celgene, Regeneron Pharmaceutical Lead Biomed Group - Investor's Business Daily 11.30.12 | 05:11 pm
